Roivant Sciences Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1,478	2,715	6,495	1,677	2,060	2,055
Short-Term Investments	3,052	2,171	-	-	-	-
Cash & Short-Term Investments	4,530	4,887	6,495	1,677	2,060	2,055
Cash Growth	-11.98%	-24.76%	287.34%	-18.62%	0.26%	-5.87%
Accounts Receivable	-	-	-	30.38	3.88	-
Other Receivables	-	-	-	7.27	2.85	-
Receivables	-	-	-	37.64	6.73	-
Inventory	-	-	-	2.76	-	-
Prepaid Expenses	-	-	-	60.83	53.37	-
Restricted Cash	2.61	2.36	3.07	5.01	3.9	77.7
Other Current Assets	127.3	110.82	233.81	15.53	22.12	54.25
Total Current Assets	4,660	5,000	6,732	1,799	2,147	2,187
Property, Plant & Equipment	97.01	101.08	59.32	92.34	86.95	77.03
Long-Term Investments	433.91	302.94	247.75	304.32	325.83	289.54
Other Intangible Assets	-	-	-	144.88	-	-
Other Long-Term Assets	34.56	32.86	183.58	49.48	25.82	36.13
Total Assets	5,225	5,437	7,222	2,390	2,585	2,590
Accounts Payable	13.29	23.69	14.03	37.83	34.58	20.55
Accrued Expenses	117.99	114.29	119.42	167.13	127.53	76.94
Current Portion of Long-Term Debt	-	-	-	40.72	-	-
Current Portion of Leases	10.44	9.84	8.97	11.69	11.4	12.31
Current Income Taxes Payable	7.17	0.42	9.77	0.54	0.71	-
Current Unearned Revenue	3.05	1.17	4.17	12.44	10.15	5.92
Other Current Liabilities	0.03	-	110.41	2.09	-	103.24
Total Current Liabilities	151.96	149.41	266.76	272.45	184.37	218.96
Long-Term Debt	-	-	-	375.52	210.03	170.28
Long-Term Leases	98.5	90.33	45.02	53.48	62.47	62.38
Other Long-Term Liabilities	0.68	10	462.18	80.58	66.84	76.06
Total Liabilities	251.14	249.74	773.95	782.02	523.7	527.69
Additional Paid-In Capital	4,944	4,562	5,396	4,933	4,422	3,815
Retained Earnings	-695	116.06	576.17	-3,773	-2,764	-1,918
Comprehensive Income & Other	20.61	9.44	-4.08	-2.62	-0.95	-98.56
Total Common Equity	4,269	4,688	5,969	1,158	1,657	1,798
Minority Interest	704.97	499.59	479.95	449.82	404.49	264.22
Shareholders' Equity	4,974	5,187	6,449	1,608	2,061	2,062
Total Liabilities & Equity	5,225	5,437	7,222	2,390	2,585	2,590
Total Debt	108.94	100.17	53.99	481.4	283.89	244.98
Net Cash (Debt)	4,421	4,787	6,441	1,195	1,777	1,810
Net Cash Growth	-12.39%	-25.68%	438.81%	-32.71%	-1.85%	-9.60%
Net Cash Per Share	6.39	6.60	7.75	1.68	2.65	2.87
Filing Date Shares Outstanding	715.7	679.81	738.72	766.81	700.77	222.67
Total Common Shares Outstanding	709.69	695.94	806.68	760.14	694.98	222.67
Working Capital	4,508	4,851	6,465	1,526	1,962	1,968
Book Value Per Share	6.02	6.74	7.40	1.52	2.38	8.07
Tangible Book Value	4,269	4,688	5,969	1,013	1,657	1,798
Tangible Book Value Per Share	6.02	6.74	7.40	1.33	2.38	8.07

Updated Feb 6, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q